Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That’s about to change.
Pharma companies, now marketing high-science drugs, rely more on medical affairs
Five years ago, the notion of medical science liaisons as a guiding voice in the marketing mix was borderline preposterous. Now they’re called upon early and often.
Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.
If asked, some will equivocate and say they get their facts from medical journals and from published studies, but never from those pesky misleading ads.
From diversity to pricing issues, BMS marketing chief strikes a balance
